Crohn'S Disease Treatment Market Revenue Growth To Experience Boost Due To Innovative Product Launches By Key Players Pfizer Inc., Boehringer Ingelheim Gmbh, F. Hoffmann-La Roche, Eli Lilly And Company, Glaxosmithkline Plc, Novartis

Crohn’s disease is a form of chronic inflammatory bowel disease (IBD) that causes inflammation in the gastrointestinal tract. This inflammation can take place anywhere between the ileum of the small intestine to the colon of the large intestine. Common symptoms of Crohn’s disease from mild to severe intensity include abdominal pain, reduced appetite, fever, and frequent diarrhea. Rectal bleeding is encountered in few cases due to fissures from inflammation at anal canal. Factors responsible for causing Crohn’s disease include hereditary genes, autoimmune reaction that causes inflammatory condition, and environmental factors such as bacteria and virus. The disease majorly affects people falling between age group of 15-35 years and occurs in moth males and females.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1237

"Market Dynamics"

The North America and Europe regions have high incidence of Crohn’s disease, which is expected to drive the growth of market. According to the journal of Gastroenterology’s on Inflammatory Bowel Disease (IBD) in 2017, around 1.6 million patient in the U.S were suffering from of IBD, out of which considerable section belongs to Crohn’s disease. Additionally, fast-track drug approval application of FDA pertaining to treatments for Crohn’s disease is also expected to foster the market in the forecast years. The pipeline drugs offering innovative treatment solutions expecting to receive marketing approvals are anticipated to propel the market growth. For instance, launch of interleukin (IL) inhibitor and anti-integrin therapy for Crohn’s disease, risankizumab, is in the Phase III clinical trials of FDA developed by AbbVie and is expected to complete its trials by January 2022. However, lack of awareness regarding available treatment options is expected to act as hindrance in the market growth.

In terms of market size, North America dominates the global Crohn’s disease treatment market. This is attributed to rapid development and launch of novel biosimilars and drugs for the treatment of disease by the key players in the market in the region. For instance, in August 2016, the U.S. Food and Drug Administration (FDA) approved two biosimilars Erelzi and Amjevita, manufactured by Amgen for the treatment of inflammatory bowel disease. Moreover, a large population pool of patients suffering from Crohn’s disease in Canada is expected to further support the growth of region in the global market.

For instance, according to the Candian Society of Intestinal Research 2011, Canada had the highest incidence of Crohn’s disease reported across the world with over 13.4 new cases per 100,000 of population. On the other hand, Asia Pacific is expected to exhibit high growth over the forecast period, owing to regional manufacturers developing biosimilars and generic versions of drugs for the treatment of Crohn’s disease. For instance, in April 2016, the U.S. Food and Drug Administration (FDA) approved Inflectra developed by Celtrion, Inc. a Korean company, which is a biosimilar to Remicade patented by Janssen Biotech, Inc. for adult and pediatric patients suffering with Crohn’s disease and have inadequate response to conventional therapies.

"Competitve Analysis"

Key players operating the global Crohn’s disease treatment market include AbbVie Inc., Janssen Biotech, Inc., Allergan Inc., Bayer AG, Bristol-Myers Squibb, Pfizer, Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche, Eli Lilly and Company, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Speak to Analyst Before Purchasing This Report: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1237

"Crohn's Disease Treatment Market Taxanomy"

Global Crohn’s Disease Treatment Market, By Drug Type:
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others

Global Crohn’s Disease Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-Commerce

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.